Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: molteni c. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.
Factors associated with hospital admission for COVID-19 in HIV patients.
Di Biagio A, Ricci E, Calza L, Squillace N, Menzaghi B, Rusconi S, Orofino G, Bargiacchi O, Molteni C, Valsecchi L, Cenderello G, Ferrara S, Saracino A, Maggi P, Falasca K, Taramasso L, Bonfanti P; CISAI Study group. Di Biagio A, et al. Among authors: molteni c. AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663. AIDS. 2020. PMID: 32796214
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
Franzetti M, Forastieri A, Borsa N, Pandolfo A, Molteni C, Borghesi L, Pontiggia S, Evasi G, Guiotto L, Erba M, Pozzetti U, Ronchetti A, Valsecchi L, Castaldo G, Longoni E, Colombo D, Soncini M, Crespi S, Maggiolini S, Guzzon D, Piconi S. Franzetti M, et al. Among authors: molteni c. J Immunol. 2021 Apr 1;206(7):1569-1575. doi: 10.4049/jimmunol.2001126. Epub 2021 Feb 5. J Immunol. 2021. PMID: 33547169 Free PMC article.
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres.
Comelli A, Genovese C, Lombardi A, Bobbio C, Scudeller L, Restelli U, Muscatello A, Antinori S, Bonfanti P, Casari S, Castagna A, Castelli F, Monforte AD, Franzetti F, Grossi P, Lupi M, Morelli P, Piconi S, Puoti M, Pusterla L, Regazzetti A, Rizzi M, Rusconi S, Zuccaro V, Gori A, Bandera A; ASP Lomb Study Group. Comelli A, et al. Antimicrob Resist Infect Control. 2022 Aug 29;11(1):108. doi: 10.1186/s13756-022-01152-5. Antimicrob Resist Infect Control. 2022. PMID: 36038903 Free PMC article.
Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco.
Conti F, Pontiggia S, Morena V, Alberton F, Badalucco F, Molteni C, Bradanini L, Pandolfo A, Galli L, Castagna A, Piconi S. Conti F, et al. Among authors: molteni c. Am J Med. 2024 Feb;137(2):e40-e41. doi: 10.1016/j.amjmed.2023.09.005. Am J Med. 2024. PMID: 38296410 No abstract available.
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy).
Ponta G, Morena V, Strano M, Molteni C, Pontiggia S, Cavalli EM, Grancini A, Mauri C, Castagna A, Galanti A, Piconi S. Ponta G, et al. Among authors: molteni c. Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0075024. doi: 10.1128/aac.00750-24. Epub 2024 Jul 12. Antimicrob Agents Chemother. 2024. PMID: 38995032 Free article.
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort.
Fois M, De Vito A, Cherchi F, Ricci E, Pontolillo M, Falasca K, Corti N, Comelli A, Bandera A, Molteni C, Piconi S, Colucci F, Maggi P, Boscia V, Fugooah A, Benedetti S, De Socio GV, Bonfanti P, Madeddu G. Fois M, et al. Among authors: molteni c. Antibiotics (Basel). 2024 Jul 2;13(7):616. doi: 10.3390/antibiotics13070616. Antibiotics (Basel). 2024. PMID: 39061297 Free PMC article.
137 results